Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer
{{output}}
Several preclinical studies suggested a potential benefit from combined treatment with inhibitors of epidermal growth factor receptor (EGFR) and angiogenesis, both effective in patients with advanced non-small-cell lung cancer (NSCLC). In pretreated patients w... ...
